Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
|
UK |
|
I
|
IFS Capital Thailand PCL
SET:IFS
|
TH |
|
Y
|
Yamazaki Co Ltd
TSE:6147
|
JP |
|
C
|
Citigroup Inc
XHAN:TRVC
|
US |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
Aisin Corp
TSE:7259
|
JP |
|
Select Sands Corp
OTC:SLSDF
|
CA |
|
Plains All American Pipeline LP
NASDAQ:PAA
|
US |
|
FIRST BANK (Hamilton)
F:6UT
|
US |
|
R
|
Royal Caribbean Cruises Ltd
SWB:RC8
|
US |
|
K
|
Kokusai Electric Corp
F:69B
|
JP |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
P
|
Puig Brands SA
MAD:PUIG
|
ES |
|
Mo-Bruk SA
F:1VX
|
PL |
|
AXA SA
XETRA:AXA
|
FR |
|
V
|
Viemed Healthcare Inc
NASDAQ:VMD
|
US |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
T
|
Tutor Perini Corp
F:PE2
|
US |
Bankruptcy Probability
Biodexa Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biodexa Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
|
823.3k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biodexa Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biodexa Pharmaceuticals PLC has no debt.
You can find a full breakdown on its Balance Sheet.